NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr

European Journal of Biochemistry

Volumn 266, Issue 2, 1999, Pages 359-369

  Wecker, K ^a   Roques, B P ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Helix turn helix motif; HIV 1; N terminal domain; NMR structure; Viral protein

Indexed keywords

GAG PROTEIN; GENE PRODUCT; HELIX LOOP HELIX PROTEIN; TRANSCRIPTION FACTOR SP1; VPR PROTEIN; PEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CIRCULAR DICHROISM; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; REGULATOR GENE; VIRION; VIROGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS REPLICATION; AMINO ACID SEQUENCE; CELL NUCLEUS; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE SYNTHESIS; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; TEMPERATURE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL NUCLEUS; CIRCULAR DICHROISM; GENE PRODUCTS, VPR; HUMANS; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE BIOSYNTHESIS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; TEMPERATURE;

EID: 0033485383     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00858.x     Document Type: Article

References (67)

1. 1. Varmus, H. & Swanstromm, R. (1985) In RNA Tumor Viruses (Weiss, R., Teich, N., Varmus, H. & Coffin, J.N., eds), pp. 369-512. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
2. 2. Emerman, M. (1996) HIV-1 and the cell cycle. Curr. Biol. 6, 1096-1103.
3. 3. Zhao, L.-J., Wang, L., Mukherjee, S. & Narayan, O. (1994) Biochemical mechanism of HIV-1 Vpr function. J. Biol. Chem. 269, 32131-32137.
4. 4. Cohen, E.A., Dehni, G., Sodroski, J.G. & Haseltine, W.A. (1990) Human immunodeficiency virus Vpr product is a virion-associated regulatory protein. J. Virol. 64, 3097-3099.
5. 5. Tristem, M., Marshall, C., Karpas, A. & Hill, F. (1992) Evolution of the primate lentiviruses: evidence from Vpx and Vpr. EMBO J. 11, 3405-3410.
6. 6. Kondo, E., Mammano, F., Cohen, E.A. & Göttlinger, H.G. (1995) The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 69, 2759-2764.
7. 7. Li, M.-S., Garcia-Asua, G., Bhattacharyya, U., Mascagni, P., Austen, B.M. & Roberts, M.M. (1996) The Vpr protein of human immunodeficiency virus type 1 binds to nucleocapsid protein p7 in vitro. Biochem. Biophys. Res. Commun. 218, 352-355.
8. 8. de Rocquigny, H., Petitjean, P., Tanchou, V., Décimo, D., Drouot, L., Delaunay, T., Darlix, J.-L. & Roques, B.P. (1997) The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J Biol. Chem. 272 (49), 30753-30759.
9. 9. Roques, B.P, Morellet, N., de Rocquigny, H., Déméné, H., Schüler, W. & Jullian, N. (1997) Structure, biological functions and inhibition of the HIV-1 proteins Vpr and NCp7. Biochimie 79, 673-680.
10. 10. Jovett, J.B.M., Planelles, V., Poon, B., Shah, N.P., Chen, ML. & Chen, I.S.Y. (1995) The human immunodeficiency, virus type 1 Vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69, 6304-6313.
11. 11. Rogel, M.E., Wu, L.I. & Emerman, M. (1995) The human immunodeficiency virus type 1 Vpr gene prevents cell proliferation during chronic infection. J Virol. 69, 882-888.
12. 12. Planelles, V, Jowett, J.B.M., Li. Q.X., Xie, Y., Hahn, B. & Chen, I.S.Y. (1996) Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70, 2516-2524.
13. 13. Bartz, S.R., Rogel, M.E. & Emerman, M. (1996) Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70, 2324-2331.
14. 14. Tung, H.Y.L., de Rocquigny, H., Zhao, L.-J., Cayla, X., Roques, B.P. & Ozon, R. (1997) Direct activation of protein phosphatase 2Ao by HIV-1 encoded protein complex NCp7/Vpr. FEBS Lett. 401, 197-201.
15. 15. Levy, D.N., Fernandes, L.S., Williams, W.V. & Weiner, D.B. (1993) Induction of cell differentiation by human immunodeficiency virus 1 Vpr. Cell 72, 541-550.
16. 16. Macreadie, I.G., Castelli, L.A., Hewish, D.R., Kirkpatrick, A., Ward, A.C. & Azad, A.A. (1995) A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc. Natl Acad. Sci. USA 92, 2770-2774.
17. 17. He, J., Choe, S., Walker, R., Di Mazio, P., Morgan, D.O. & Landau, N.R. (1995) Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibting P34cdc2 activity. J. Virol. 69, 6705-6711.
18. 18. Stewart, S.A., Poon, B., Jowet, J.B. & Chen, I.S. (1997) Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71, 5579-5592.
19. 19. Conti, L., Rainaldi, G., Matarrese, P., Varano, B., Rivabene, R., Columba, S., Sato, A., Belardelli, F., Malorni, W. & Gessani, S. (1998) The HIV-1 Vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS, J. Exp. Med. 187, 403-413.
20. 20. Stark, L.A. & Hay, R.T. (1998) Human immunodeficiency virus type 1 (HIV-1 viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription. J. Virol. 72, 3037-3044.
21. 21. Zhao, L.-J., Mukherjee, S. & Narayan, O. (1994) Biochemical mechanism of HIV-1 Vpr function: specific interaction with a cellular protein. J. Biol. Chem. 269, 15577-15582.
22. 22. Lu, Y.-L., Spearman, P. & Ratner, L. (1993) Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67, 6542-6550.
23. 23. Yao, X.-J., Subbramanian, R.A., Rougeau, N., Boisvert, F., Bergeron, D. & Cohen, E.A. (1995) Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69. 7032-7044.
24. 24. Refaeli, Y., Levy, D.N. & Weiner, D.B. (1995) The glucocorticoid receptor type II complex is a target of the HIV-1 Vpr gene product. Proc. Naitl Acad. Sci. USA 92, 3621-3625.
25. 25. Vodicka, M.A., Koepp. D.M., Silver, P.A. & Emerman, M. (1998) HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Gen. Dev. 12, 175-185.
26. 26. Popov, S., Rexach, M., Zyharth, G., Reiling, V., Lee, M.A., Ratner, L., Lane, M.A., Moore, M.S., Blodel, G. & Bukrinsky, M. (1998) Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17, 909-917.
27. 27. Bouhamdan, M., Benichou, S., Rey, F., Navarro, J.-M., Agostini, I., Spire, B., Camonis, J., Slupphaug, G., Vigne, R., Benarous, R. & Sire, J. (1996) Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70, 697-704.
28. 28. Agostini, I., Navarro, J.-M., Rey, F., Bouhamdan, M., Spire, B., Vigne, P. & Sire, J. (1996) The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB. J. Mol. Biol. 261, 599-606.
29. 29. Bouhamdan, M., Xue, Y., Baudat, Y., Hu, B., Sire, J., Pomerantz., R.J. & Duan, L.X. (1998) Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins. J. Biol Chem. 273, 8009-8016.
30. 30. Geourjon, C., Deleage, G. & Roux, B. (1991) ANTREPROT: an interactive graphics software for analyzing protein structures from sequences. J. Mol. Graph. 9, 188-190.
31. 31. Frishman, D. & Argos, P. (1995) Knowledge-based protein secondary structure assignment. Proteins 23, 566-579.
32. 32. Eisenhaber, F., Imperiale, F., Argos. P. & Froemmel, C. (1996) Prediction of secondary structural content of proteins from their amino acid composition alone. II. The paradox with secondary structural class. Proteins 25 (N2), 169-179.
33. 33. Schüler, W., Wecker, K., de Rocquigny, H., Baudat, Y, Sire, J. & Roques, B.P. (1999) NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: Molecular insights into its biological functions. J. Mol. Biol. 285 (5), 2105-2117.
34. 34. de Rocquigny, H., Ficheux, D., Gabus, C., Fournié-Zaluski. M.C., Darlix, J.-L. & Roques, B.P. (1991) First large scale chemical synthesis of the 72 amino acids HIV-1 nucleocapsid protein NCp7 in an active form. Biochem. Biophys. Res. Commun. 180, 1010-1018.
35. 35. De Rocquigny, H., Gabus, C., Vincent, A., Fournié-Zaluski, M.C., Roques, B.P. & Darlix, J.L. (1992) Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl Acad. Sci. USA 89, 6472-6476.
36. 1H spin system identification in macromolecules. J. Am. Chem. Soc. 110, 7870-7872.
37. 37. Jeener, J., Meier, B.H., Bachmann, P. & Ernst, R.R. (1982) Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 71, 4546-4553.
38. 1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113, 967-974.
39. 39. Wüthrich, K. (1983) NMR of Proteins and Nucleic Acids. Wiley, New York.
40. 40. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids. Wiley-Interscience, New York.
41. 1H NMR. EMBO J. 11, 3059-3065.
42. 42: Alder, A.J., Grennfiled, N.J. & Fasman, G.D. (1973) Methods Enzymol. 27, 675-735.
43. 43. O'Shea, E.K., Rutkowski, R. & Kim, P.S. (1989) Evidence that the leucine zipper is a coiled coil. Science 243, 538-542.
44. 44. O'Shea, E.K., Rutkowski, R., Stafford, W.F. & Kim, P.S. (1989) Preferential heterodimer formation by isolated leucine zippers from Fos and Jun. Science 245, 646-648.
45. 45. Segawa, S.-I., Fukuno, T., Fujiwara, K. & Noda, Y. (1991) Local structures in unfolded lysozyme and correlation with secondary structures in the native conformation: helix-forming or -breaking propensity of peptide segments. Biopolymers 31, 497-509.
46. 46. Dyson, HJ., Merukta, G., Waltho, J.P., Lerner, R.A. & Wright, E.P. (1992) Folding of peptide fragments comprising the complete sequence of proteins. Models for initiation of protein folding. I. Myohemerythrin. J. Mol. Biol. 226, 795-817.
47. 47. Mahalingam, S., Ayyavoo, V., Patel, M., Kieber-Emmons, T. & Weiner, D.B. (1997) Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol. 71, 6339-6347.
48. 48. Kami, O., Friedler, A., Zakai, N., Gilon, C. & Loyter, A. (1998) A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: Elucidation of the NLS region of the Vpr. FEBS Lett. 429, 421 -425.
49. 49. Lu, Z.-X., Fok, K.-F., Erickson, B.W. & Hugh, T.E. (1984) Conformational analysis of COOH-terminal segments of human C3a. J. Biol. Chem. 259, 7367-7370.
50. 50. Leist, T. & Thomas, R.M. (1984) Synthesis and physicochemical characterization of major fragments of human leucocyte interferon γ. Biochemistry 23, 2541-2547.
51. 51. Dyson, H.J., Ranee, M., Houghten, R.A., Wright, P.E. & Lerner, R.A. (1988) Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix. J. Mol. Biol. 201, 201-218.
52. 1H NMR spectroscopy. Biochemistry 27, 4032-4040.
53. 53. Nelson, J.W. & Kallenbach, N.R. (1989) Persistence of the alpha-helix stop signal in the S-peptide in trifluoroethanol solutions. Biochemistry 28, 5256-5261.
54. 54. Blanco, F.J., Jiménez, M.A., Pineda, A., Rico, M., Santoro, J. & Nieto, J.L. (1994) NMR solution structure of the isolated N-terminal fragment of protein-G Bl domain. Evidence of trifluoroethanol induced native-like β-hairpin formation. Biochemistry 33, 6004-6014.
55. 55. Jimenez, M.A., Munoz, V, Rico, M. & Serrano, L. (1994) Helix stop and start signals in peptides and proteins. The capping box does not necesarily prevent helix elongation. J. Mol. Biol. 242, 487-496.
56. 56. Heinzinger, N.K., Bukrinsky, M.I., Haggerty, S.A., Ragland, A.M., Kewalramani.V, Lee, M.A., Gendelman, H.E., Ratner, L., Stephenson, M. & Emerman, M. (1994) The Vpr protein of human immunodeficiency virus type I influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl Acad. Sci. USA 91, 7311-7315.
57. 57. Wu, X., Conway, J.A., Kim, J. & Kapps, J.C. (1994) Localization of the Vpx packing signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein. J. Virol. 68, 6161-6169.
58. 58. Gras-Masse, H., Ameisen, J.C., Boutillon, C., Gesquière, J.C., Vian, S., Neyrinck, J.L., Drobecq, H., Capron, A. & Tartar, A. (1990) A synthetic protein corresponding to the entire Vpr gene product from the human immunodeficiency virus HIV-1 is recognized by antibodies from HIV-1 infected patients. IM. J. Pept. Protein Res. 36, 219-226.
59. 59. Yuan, X., Matsuda, Z., Matsuda, M., Essex, M. & Lee, T.-H. (1990) Human immunodeficiency virus Vpr gene encodes a virionassociated protein. AIDS Res. Hum. Retroviruses 6, 1265-1271.
60. 60. Paxton, W., Connor, R.I. & Landau, N.R. (1993) Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67, 7229-7237.
61. 61. Lu, Y.-L., Bennet, R.B., Wills, J.W., Gorelick, R. & Ratner, L. (1995) A leucine triplet repeat sequence (LXX) 4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J. Virol. 69, 6873-6879.
62. 62. Mahalingam, S., Collman, R.G., Patel, M., Monken, C.E. & Srinivasan, A. (1995) Functional analysis of HIV-1 Vpr: Identification of determinants essential for subcellular localization. Virology 212, 331 -337.
63. 63. Mahalingam, S., Khan, S.A., Murali. R., Jabhar, M.A., Monken, C.E., Collman, R.G. & Srinivasan, A. (1995) Mutagenesis of the putative α-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation. Proc. Natl Acad. Sci. USA 92, 3794-3798.
64. 64. Di Marzio, P., Choe, S., Ebright, M., Knoblauch, R. & Landau, N.R. (1995) Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69, 7909-7916.
65. 65. Bukrinsky, M.I. & Haffar, O.K. (1998) HIV-1 nuclear import: Matrix protein is back on center stage, this time together with Vpr. Mol. Med. 4, 138-143.
66. 66. Hu, T., Guan, T. & Gerace, L. (1996) Molecular and functional characterization of the p62 complex, an assembly of nuclear pore complex glycoproteins. J. Cell Biol. 134, 589-601.
67. 67. Piller, S.C., Ewart, G.D., Premkumar, A., Cox, G.B. & Gage, P.W. (1996) Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc. Natl Acad. Sci. USA 93, 111-115.